期刊
NATURE CHEMICAL BIOLOGY
卷 7, 期 2, 页码 92-100出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/NCHEMBIO.503
关键词
-
资金
- US National Institutes of Health [RO1 CA128803-03]
- Massachusetts Institute of Technology Department of Biology
- American Association for Cancer Research
- Integrated Cancer Biology Program [1-U54-CA112967]
Identifying mechanisms of drug action remains a fundamental impediment to the development and effective use of chemotherapeutics. Here we describe an RNA interference (RNAi)-based strategy to characterize small-molecule function in mammalian cells. By examining the response of cells expressing short hairpin RNAs (shRNAs) to a diverse selection of chemotherapeutics, we could generate a functional shRNA signature that was able to accurately group drugs into established biochemical modes of action. This, in turn, provided a diversely sampled reference set for high-resolution prediction of mechanisms of action for poorly characterized small molecules. We could further reduce the predictive shRNA target set to as few as eight genes and, by using a newly derived probability-based nearest-neighbors approach, could extend the predictive power of this shRNA set to characterize additional drug categories. Thus, a focused shRNA phenotypic signature can provide a highly sensitive and tractable approach for characterizing new anticancer drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据